Digital Journal
Flightpath Biosciences Begins Human Clinical Testing of the World’s First Narrow-Spectrum Antibiotic Targeting Lyme Disease
DETROIT, MI / ACCESSWIRE / May 10, 2024 / Flightpath Biosciences Inc., a clinical-stage life sciences company developing therapeutics to treat infectious diseases, announced today that the first ...
2 hours ago